Current strategies for treatment and management of gliomas incorporate molecular markers to individualize patient care. Physiologic imaging identifies treatment-associated alterations in tissue properties including cellular viability, vascular function, and molecular response. Imaging biomarkers provide a noninvasive approach for early treatment response assessment and are an important tool to individualize patient management. Gliomas are heterogeneous tumors. Parametric response mapping (PRM) is a novel voxel-wise imaging analysis method which directly addresses the issue of tumor heterogeneity. PRM image analysis improves the predictive accuracy of imaging biomarkers in clinical applications including treatment response assessment. A multi-parametric imaging biomarker derived from MR perfusion and diffusion-weighted imaging (DWI) using a PRM analysis method provides early identification of high-grade glioma chemoradiation resistance. Further validation of PRM-derived imaging biomarkers is required prior to routine clinical application as an early treatment response marker.
CITATION STYLE
Cardenas, M., Galban, C. J., Chenevert, T. L., Miller-Thomas, M., Ross, B. D., & Tsien, C. (2019). Parametric Response Map (PRM) Analysis Improves Response Assessment in Gliomas. In Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches (pp. 109–126). Springer International Publishing. https://doi.org/10.1007/978-3-030-27359-0_7
Mendeley helps you to discover research relevant for your work.